Divergent effects of AKI to CKD models on inflammation and fibrosis

L. M. Black, J. M. Lever, A. M. Traylor, B. Chen, Z. Yang, S. K. Esman, Y. Jiang, G. R. Cutter, R. Boddu, J. F. George, A. Agarwal

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


Chronic kidney disease (CKD) is a condition with significant morbidity and mortality that affects 15% of adults in the United States. One cause of CKD is acute kidney injury (AKI), which commonly occurs secondary to sepsis, ischemic events, and drug-induced nephrotoxicity. Unilateral ischemia-reperfusion injury (UIRI) without contralateral nephrectomy (CLN) and repeated low-dose cisplatin (RLDC) models of AKI to CKD demonstrate responses characteristic of the transition; however, previous studies have not effectively compared the pathogenesis. We demonstrate both models instigate renal dysfunction, inflammatory cytokine responses, and fibrosis. However, the models exhibit differences in urinary excretory function, inflammatory cell infiltration, and degree of fibrotic response. UIRI without CLN demonstrated worsening perfusion and function, measured with99mTc-mercaptoacetyltriglycine-3 imaging, and physiologic compensation in the contralateral kidney. Furthermore, UIRI without CLN elicited a robust inflammatory response that was characterized by a prolonged polymorphonuclear cell and natural killer cell infiltrate and an early expansion of kidney resident macrophages, followed by T-cell infiltration. Symmetrical diminished function occurred in RLDC kidneys and progressively worsened until day 17 of the study. Surprisingly, RLDC mice demonstrated a decrease in inflammatory cell numbers relative to controls. However, RLDC kidneys expressed increased levels of kidney injury molecule-1 (KIM-1), high mobility group box-1 (HMGB1), and colony stimulating factor-1 (CSF-1), which likely recruits inflammatory cells in response to injury. These data emphasize how the divergent etiologies of AKI to CKD models affect the kidney microenviron-ment and outcomes. This study provides support for subtyping AKI by etiology in human studies, aiding in the elucidation of injury-specific pathophysiologic mechanisms of the AKI to CKD transition.

Original languageEnglish
Pages (from-to)F1107-F1118
JournalAmerican Journal of Physiology - Renal Physiology
Issue number4
StatePublished - 5 Oct 2018
Externally publishedYes


  • Chronic kidney disease
  • Cisplatin
  • Fibrosis
  • Glomerular filtration rate
  • Inflammation
  • Ischemia-reperfusion


Dive into the research topics of 'Divergent effects of AKI to CKD models on inflammation and fibrosis'. Together they form a unique fingerprint.

Cite this